Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail Dirks

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|July 17, 2023
Is Your Organization's Remote Work Strategy "Working"? Exploring the Impact of Employees' Attitudes Toward Flexible Work Arrangements on Inclusion and Turnover IntentionJennifer Kim, Abigail Dirks
Therapeutic Innovation & Regulatory Science|June 8, 2025
Trends in the Burden for Patients Participating in Industry-Funded Clinical TrialsAbigail Dirks, Emily Botto, Zachary Smith, et al.
Human Vaccines & Immunotherapeutics|April 13, 2026
Quantifying vaccine dissemination for uptake comparisons between vaccinesAbigail Dirks, Hana Do, Madison Ford, et al.
Therapeutic Innovation & Regulatory Science|February 14, 2025
Adoption Maturity Model for Risk-based Quality Management (RBQM) in Clinical TrialsMaria Florez, Abigail Dirks, Linda Sullivan, et al.
Therapeutic Innovation & Regulatory Science|June 25, 2026
Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical DevelopmentAbigail Dirks, Sylviane de Viron, Kenneth McFarlane, et al.
Therapeutic Innovation & Regulatory Science|February 17, 2024
Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical TrialsAbigail Dirks, Maria Florez, Francois Torche, et al.
Therapeutic Innovation & Regulatory Science|April 30, 2024
Correction: Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical TrialsAbigail Dirks, Maria Florez, Francois Torche, et al.
Therapeutic Innovation & Regulatory Science|April 3, 2024
Benchmarking Site Activation and Patient EnrollmentMary Jo Lamberti, Abigail Dirks, Nicholas Kikuchi, et al.
Therapeutic Innovation & Regulatory Science|August 21, 2025
Measuring Patient Participation Burden in Clinical Outcome Assessments for Clinical TrialsAbigail Dirks, Hana Do, Chelsea Gallagher, et al.
PLOS Digital Health|March 10, 2026
How exclusion criteria can hinder eligibility for lung cancer studies among different racial and ethnic groupsJennifer Y Kim, Abigail Dirks, Ruby Madison Ford, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|July 17, 2023
Is Your Organization's Remote Work Strategy "Working"? Exploring the Impact of Employees' Attitudes Toward Flexible Work Arrangements on Inclusion and Turnover IntentionJennifer Kim, Abigail Dirks
Therapeutic Innovation & Regulatory Science|June 8, 2025
Trends in the Burden for Patients Participating in Industry-Funded Clinical TrialsAbigail Dirks, Emily Botto, Zachary Smith, et al.
Human Vaccines & Immunotherapeutics|April 13, 2026
Quantifying vaccine dissemination for uptake comparisons between vaccinesAbigail Dirks, Hana Do, Madison Ford, et al.
Therapeutic Innovation & Regulatory Science|February 14, 2025
Adoption Maturity Model for Risk-based Quality Management (RBQM) in Clinical TrialsMaria Florez, Abigail Dirks, Linda Sullivan, et al.
Therapeutic Innovation & Regulatory Science|June 25, 2026
Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical DevelopmentAbigail Dirks, Sylviane de Viron, Kenneth McFarlane, et al.
Therapeutic Innovation & Regulatory Science|February 17, 2024
Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical TrialsAbigail Dirks, Maria Florez, Francois Torche, et al.
Therapeutic Innovation & Regulatory Science|April 30, 2024
Correction: Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical TrialsAbigail Dirks, Maria Florez, Francois Torche, et al.
Therapeutic Innovation & Regulatory Science|April 3, 2024
Benchmarking Site Activation and Patient EnrollmentMary Jo Lamberti, Abigail Dirks, Nicholas Kikuchi, et al.
Therapeutic Innovation & Regulatory Science|August 21, 2025
Measuring Patient Participation Burden in Clinical Outcome Assessments for Clinical TrialsAbigail Dirks, Hana Do, Chelsea Gallagher, et al.
PLOS Digital Health|March 10, 2026
How exclusion criteria can hinder eligibility for lung cancer studies among different racial and ethnic groupsJennifer Y Kim, Abigail Dirks, Ruby Madison Ford, et al.
Pageof 2